Skip to main content
Clinical Trials/NCT05679843
NCT05679843Not yet recruitingNot Applicable

Characteristics and Prognosis of STEMI Patients Undergoing Primary PCI According to Coronary Occlusion Physiopathogeny and/or Atherosclerotic Burden

Central Hospital, Nancy, France0 sites3,000 target enrollmentStarted: June 7, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
3,000
Primary Endpoint
Composite outcome including all cause death and re myocardial infarction

Study Overview

Brief Summary

Gensini score (GS) provides valuable information on severity and prognosis of coronary artery disease (CAD). We aim to evaluate the relationship between the severity of CAD determined by the GS and short and long term of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with STEMI underwent primary PCI within 24 hours after first symptoms

Exclusion Criteria

  • Patients with STEMI 24 hours after first symptoms Pregnant patient <18 years old

Outcomes

Primary Outcomes

Composite outcome including all cause death and re myocardial infarction

Time Frame: 6 years

Secondary Outcomes

  • ST resolution on ECG after primary PCI(1 hour)

Investigators

Sponsor
Central Hospital, Nancy, France
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Batric POPOVIC

MD,PhD

Central Hospital, Nancy, France

Similar Trials